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Objective: Spinal fusion surgery is a common treatment modality for various pathologic 
conditions of the spine. The bone morphogenetic protein 2 (BMP2) analogue L51P acts as a 
general inhibitor of BMP antagonists, whereas it shows a weak affinity for BMP type I re-
ceptor. It is suggested that L51P applied in bone disorders might prevent side effects of 
highly concentrated BMP dosage applications in the order of milligrams. The objective of 
this study was to investigate the effects of L51P and BMP2 on intervertebral disc cells 
(IVDCs), i.e. on nucleus pulposus cells, on annulus fibrosus cells (AFCs), and on cartilagi-
nous endplate cells (CEPCs), respectively, in 3-dimensional (3D) culture.
Methods: Low-passage primary IVDCs were cultured in 3D alginate bead culture and ex-
posed to 100-ng/mL BMP2 and/or L51P for 21 days. Here, we analyzed glycosaminoglycan 
(GAG) and DNA content and further performed gene expression analysis for major matrix 
genes.
Results: AFCs and cartilaginous CEPCs stimulated with each 100-ng/mL L51P and BMP2, 
showed a significant upregulation in GAG (AFCs: p = 0.00347 and CEPCs: p = 0.0115) 
and DNA production (AFCs: p = 0.0182 and CEPCs: p = 0.0179) compared to control.
Conclusion: These results allow first insights into the behavior of IVDCs upon L51P stimu-
lation.
Keywords: BMP2, L51P, Intervertebral disc cells
INTRODUCTION
Spinal fusion surgery is a common treatment modality for 
various pathologic conditions of the spine, including degenera-
tive disorders, trauma, tumours and deformities. Anterior, pos-
terior or combined anteroposterior fusion are technically dis-
tinguished. Anterior fusion includes removal of the interverte-
bral disc (IVD), followed by insertion of a structural graft or 
spacer/cage.1 Additional fixation with pedicle screw/rod con-
structs or plating are frequently used to maintain mechanical 
stability until osseous fusion is reached. Although lumbar fu-
sion is an effective clinical treatment, the prevalence of nonunion 
and/or pseudoarthrosis ranges between 5% and 35%.2 Nonunion 
is defined as lack of solid osseous fusion 1 year after surgery.3 
Predictors of failure of a union are excessive motion, metabolic 
abnormalities, smoking, trauma and infection. Lately, clinical 
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observations indicate that partial removal of the disc could lead 
to nonunion.4,5 Recent studies have shown that mesenchymal 
stromal cells (MSCs) are prevented from undergoing osteogen-
esis when cocultured with IVD cells.6,7 Several bone morphoge-
netic proteins (BMPs) are effective stimulators of osteogenesis. 
BMP2 and 7, which are U.S. Food and Drug Administration 
approved, are used in clinics as osteoinductive factors during 
spinal fusion.8 However, the applied supraphysiological doses of 
BMPs raise safety concerns.9 One essential pathway to induce 
osteogenic differentiation is the BMP signalling pathway.10 After 
the discovery of BMPs in 1965 by the surgeon Marshall R. Urist, 
many studies aimed to prove the beneficial effects of these pro-
teins in the skeleton.11 BMPs bind to serotonin/threonine kinase 
receptors; the activated BMP receptors phosphorylate carboxy-
terminally the Smad 1/5/8 complex, which is then forming het-
eromers with Smad 4. The complex then translocates to the nu-
cleus, where activation or inhibition activity is initiated.12 BMP 
antagonists like GREM1 (gremlin1), GREM2 (gremlin2), NOG 
(noggin), CHRD (hordin), FLST (follistatin), and TWSG (twist-
ed gastrulation) bind with different affinities to BMPs, thus pre-
venting the interaction of BMPs with their specific receptors 
(Fig. 1). One possible reason for the inhibition of bone forma-
tion during spinal fusion could be the presence of different 
BMP antagonists, which might be secreted from remaining 
IVD tissue. We and others have recently shown that BMP an-
tagonists are expressed in IVD cells.4,7,13 It has been debated 
whether supraphysiological doses of BMP2 should be applied in 
clinics. Furthermore, these high doses of BMPs often lead to ad-
verse effects.14 Additionally, BMPs are known for their pleiotro-
pic character, which means that they might induce inadvertent 
effects in other tissues.15 The BMP2 variant L51P could be a 
possible solution for the reduction of BMP dosis and efficacy in 
clinics. This analogue has one amino acid substituted with leu-
cine to proline at position 51. L51P has a lower affinity to 
BMPR type I (BMPRI) but binds to BMPR type II (BMPRII) 
with similar affinity as does wild-type BMP2.16,17 The affinity for 
binding to the BMP antagonists, however, remains the same as 
for the wild-type.16 Several studies have demonstrated the in-
creased bioefficacy of exogenous and endogenous BMP2 if 
L51P was applied in combination in primary murine osteo-
blasts, MC3T3-E1, ATCDC5 and pro-myoblasts.18-20 Hauser et 
al.21 have even demonstrated improved bone formation by L51P 
and BMP2 in an in vivo mouse model. So far, most studies in-
vestigated the effect of BMP2 on IVD cells for regenerative pur-
poses. It has recently been speculated that IVDs could probably 
demonstrate plasticity and undergo osteogenic differentiation 
under certain conditions or might resist to osteogenic stimuli 
by an unknown mechanism. Recent studies have shown chon-
drogenic, others even osteogenic, differentiation of IVD cells if 
stimulated with BMP2.22 However, our group demonstrated an 
apparent deblocking effect of L51P in the case of MSCs in co-
culture with IVD cells.7 Thus, this study aimed to investigate 
whether exogenous stimulation of L51P and BMP2 has a stimu-
lating effect on metabolism, gene expression and extracellular 
matrix (ECM) production on 3 different IVD cells, that is, nu-
cleus pulposus cells (NPCs), annulus fibrosus cells (AFCs), and 
cartilaginous endplate cells (CEPCs).
MATERIALS AND METHODS
1. IVD Donor Material and Cell Isolation
IVDs were obtained from patients undergoing spinal surgery. 
All procedures were approved by the ethics committee of the 
Canton of Bern and were performed with the patients’ written 
consent. All tissue was processed within 24 hours after surgery. 
Human IVD tissue was separated into nucleus pulposus, annu-
Fig. 1. Overview of bone morphogenetic proteins (BMPs), 
BMP antagonists, and the BMP2 analogue L51P.
Table 1. Donor list of intervertebral disc cells obtained from 
trauma surgery
Passage Age (yr) Sex Pfirmann grade Level
2 28 M 1 L4/L5
2 42 F 2 L3/L4
2 35 NA 1 L2/L3
2 22 F 1 L3/L4
2 22 F 1 T12/L1
2 32 M 1 T12/L1
NA, not available.
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lus fibrosus and cartilaginous endplate tissue by an experienced 
surgeon. IVD cells were obtained from 5 donors from 22 to 32 
years in age (31.8± 3.4 years). One patient was the donor of 2 
IVDs from different levels (Table 1).
Subsequently, IVD cells were isolated from their native ECM 
as described previously.13,23 Briefly, cells were isolated by pro-
nase (Roche, Basel, Switzerland) followed by collagenase type 2 
(Worthington, London, UK) enzymatic digestion as previously 
reported. NPCs, AFCs and CEPCs were expanded in prolifera-
tion medium (low-glucose [1g/L] Dulbecco’s Modified Eagle 
Medium supplemented with 10% foetal bovine serum [FBS] 
and penicillin/streptomycin [P/S]).
2. Cell Encapsulation and Stimulation
NPCs, AFCs, and CEPCs were encapsulated at a density of 4 
Mio/mL in 1.2% alginate (Fluka, Sigma-Aldrich, Buchs, Swit-
zerland). The cell-alginate suspension was dropped into 102 
mM CaCl2 using a syringe (22-G needle)24 and a syringe pump 
to set the flow rate (1.8 mL/min). NPC, AFC, and CEPC beads 
were then stimulated with 100 ng/mL (33 nM) of either BMP2, 
L51P, and BMP2+L51P. The cytokines were supplied in osteo-
genic medium (OM, α-minimal essential medium (α-MEM) 
supplemented with 10% FBS, P/S, 50 µg/mL Vit C, 10 nM dexa-
methasone and 5 mM β-glycerophosphate [all purchased from 
Sigma-Aldrich]) or basal medium (BM, α-MEM, supplement-
ed with 10% FBS and P/S). The 3 control groups included BM 
and OM only stimulation and β-glycerophosphate control (α- 
MEM supplemented with 10% FBS, P/S, and 5 mM β-glycero-
phosphate [β-GP control]). The experimental groups are de-
picted in Fig. 2.
3. Histological Staining of Proteoglycans
The beads were embedded on day 21 in Tissue-TEK O.C.T. 
compound (Sysmex, Horgen, Switzerland), frozen in liquid ni-
trogen, stored at -80°C and then cut into 12-µm sections using 
a cryostat (microm HM560, Thermo Fisher Scientific, Basel, 
Switzerland). Sections were then stained with Alcian Blue (Sig-
ma-Aldrich) (pH, 1) solution containing 0.1 M CaCl2 for 30 
minutes at 37°C to visualize sulfated GAGs. Generally, all solu-
tions for the staining contained CaCl2, to avoid dissolution of 
the beads. After mounting in Aquatex (cat# 108562, Sigma-Al-
drich) sections were examined by light microscopy.
4.  Analysis of Specific Gene Expression in IVD 3D Culture 
With Quantitative Polymerase Chain Reaction
Snap-frozen alginate beads were pulverized using liquid ni-
trogen and a precooled mortar and pestle. Pulverized beads 
were then suspended in TRI reagent (Molecular Research Cen-
ter, Cincinnati, OH, USA). The total RNA extraction method 
was performed as described before using a combined phase 
separation and silicon column method.13 After RNA isolation, 
possible remaining DNA was digested using DNase I (AMP-
D1, Sigma-Aldrich) for 15 minutes. Reverse transcription (RT) 
was performed using all-in-one cDNA Synthesis SuperMix (Bi-
make, Houston, TX, US; distributed by LuBioScience GmbH, 
Lucerne, Switzerland). Real-time quantitative polymerase chain 
reaction (qPCR) was performed in duplicate using SYBR Green 
PCR master mix on a CFX96 touch qPCR system (all from Bio-
Rad, Reinach, Switzerland). Genomic (no RT) and negative 
controls were included to ensure the quality of RNA extractions 
and the PCR. The IVD cells were investigated for IVD marker 
genes, that is, aggrecan (ACAN), collagen type 1 (COL1) and 
collagen type 2 (COL2; Table 2). Microsynth Inc. (Balgach, Swit-
zerland) synthesized all primers, all of which were tested for ef-
ficiency. qPCR was conducted using a 2-step protocol with an 
annealing temperature of 61°C for 40 seconds and 95°C for 15 
seconds for 45 cycles. Amplicon specificity was ensured by con-
ducting melting curve analysis after cycling. CFX-96 cycler 
software v 3.1 (Bio-Rad) was used for the quantification analy-
sis of relative gene expression. The number of PCR cycles need-
Fig. 2. Experimental design of human intervertebral disc cells, 
i.e., nucleus pulposus (NPCs), annulus fibrosus (AFCs), and 
cartilaginous endplate cells (CEPCs) (encapsulated in 1.2% 
alginate) stimulation with 100-ng/mL bone morphogenetic 
protein 2 (BMP2) and/or L51P in osteogenic or basal medium 
for 21 days. Not shown are the 3 controls, basal and osteogen-
ic medium only stimulation and β-glycerophosphate control 
(α-minimal essential medium supplemented with 10% foetal 
bovine serum, penicillin/streptomycin, and 5 mM β-glycero-
phosphate).
100 ng/mL 
BMP2 or L51P
Osteogenic 
medium or  
basal medium
 Stimulation BMP2 L51P BMP2+L51P
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ed for each sample to reach the threshold level was recorded as 
the Cq value.25 ∆∆Cq values were normalized relative to day 0 
or negative control and transformed into relative mRNA values 
using the formula 2−∆∆Cq and 2 reference genes (18S and GAP-
DH, respectively).26
5. Mitochondrial Activity
On days 7, 14, and 21, 3 beads were collected and immersed 
in 50 µM resazurin sodium salt solution (Sigma-Aldrich) and 
incubated for 2 hours at 37°C. Mitochondrial activity of osteo-
blasts and MSC monolayers was measured after 21 days by in-
cubating the cells for 30 minutes at 37°C. Relative fluorescence 
units were read on a plate reader at an excitation wavelength of 
547 nm and an emission wavelength of 582 nm using an M5 
Spectramax plate reader (Molecular Devices, LLC., distributed 
by Bucher Biotec, Switzerland).
6. DNA, GAG, and Hydroxyproline Content
Beads were digested overnight at 60°C in a 4.9-IE/mL papain 
solution containing papain from Papaya latex (Sigma-Aldrich). 
Three beads were digested in 450-µL papain solution. Subse-
quently, DNA was determined using a bisbenzimide fluorescent 
dye (Hoechst 3258, Sigma-Aldrich) and a standard curve from 
calf thymus DNA (Sigma-Aldrich). The fluorescence was mea-
sured at a wavelength of 350 nm (excitation) and 450 nm (emis-
sion) using an M5 Spectramax plate reader.
GAG content of the papain-digested samples was quantified 
using 1,9-dimethylmethylene blue (Sigma-Aldrich) binding as-
say.27 Absorbance was measured at 600 nm using an M5 Spec-
tramax plate reader. A standard curve obtained using chondroi-
tin sulfate (Sigma-Aldrich) allowed calculation of the GAG con-
centrations.
Hydroxyproline (OHP) content was measured to determine 
the total amount of collagen within the papain-digested sam-
ples. To release OHP from the digested sample, hydrolysation 
was induced with 12M HCl at 95°C for 20 hours followed by 
neutralisation by adding equimolar NaOH to the sample. The 
solution was pretreated with a 1:1 mix of charcoal (Fluka, Sig-
ma-Aldrich) and resin (Bio-Rad) to eliminate interfering sub-
stances or colour inhibition. The colour reaction was induced 
by adding chloramine T and para-dimethylaminebenzoalde-
hyde to the sample. A standard curve was obtained with L-4-hy-
droxy-proline (Sigma-Aldrich). The absorbance was measured 
at 560 nm using an M5 Spectramax plate reader.
7. Statistics
All assays were run in technical duplicates. Statistical analysis 
was performed on biological replicates, that is, donor cell repe-
titions. The statistical analysis was performed using PRISM 7.0 
software for Mac OS X (GraphPad, La Jolla, CA, USA). Values 
are given as means± standard error of the mean. Shapiro-Wilk 
normality test for parametric distribution was performed. As 
some data were not-normally distributed and the sample sizes 
(n= 4) were nonparametric, Kruskal-Wallis test was performed 
to test statistical significance followed by Dunn multiple com-
parison test.
8. IVD Cells in 3D Culture
Gene expression measured from 2 donors after 7 days in cul-
ture showed a trend for upregulation of ACAN in groups with 
BMP2 or L51P stimulation. In all 3 cell types (NPCs, AFCs, and 
CEPCs) ACAN expression was the most upregulated if cells were 
stimulated with OM and 100-ng/mL BMP2 and L51P compared 
with negative control (BM only: mean NPCs, 19.0; AFCs, 11.4; 
and CEPCs, 31.9-fold increase). The same could be observed 
for COL2 expression (NPCs, 72.5; AFCs, 4.4; CEPCs, 66.1). How-
ever, COL1 changed only slightly, again with the highest COL1 
expression in groups stimulated with OM supplemented with 
Table 2. List of genes analyzed by quantitative polymerase chain reaction of human primary intervertebral disc cells
Name Description Accession No. Primer forward Primer reverse
18S Ribosomal 18S RNA gene NR_145820.1 CGA TGC GGC GGC GTT ATT C TCT GTC AAT CCT GTC CGT 
GTCC
ACAN Aggrecan XM_017021987.1 AAG GCT GCT ATG GAG ACA A ACT CAT TGG CTG CTT CCT
COL1A2 (COL1) Collagen type I α2 chain NM_000089.3 GTG GCA GTG ATG GAA GTG CAC CAG TAA GGC CGT TTG
COL2A1 (COL2) Collagen type II α1 chain XM_017018831.1 AGC AGC AAG AGC AAG GAG AA GTA GGA AGG TCA TCT GGA
GAPDH Glyceraldehyde-3-phos-
phate dehydrogenase
NM_001289745.2 ATC TTC CAG GAG CGA GAT GGA GGC ATT GCT GAT GAT
RUNX2 Runt-related transcription 
factor 2
NM_001024630 AGC AGC ACT CCA TAT CTC T TTC CAT CAG CGT CAA CAC
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BMP2 and L51P (NPCs, 2.5; AFCs, 1.4; CEPCs, 7.2). RUNX2 
also showed upregulation in NPCs stimulated with OM and 
L51P or BMP2 and costimulation (Fig. 3).
9. GAG, DNA, and OHP Content of IVD Cells in 3D Culture
BM supplemented with BMP2 and L51P showed a signifi-
cantly higher GAG content in AFC (p = 0.00347) and CEPC 
(p = 0.0115) compared with respective control groups in BM 
(Fig. 4A). Also, the DNA content of CEPCs and AFCs stimulat-
ed with BM and BMP2 + L51P showed the trend to be higher 
than in the respective group stimulated with BM only (Fig. 4B). 
The DNA/GAG ratio was relatively stable in all groups (Fig. 
4C). The measured OHP content was rather low in all groups 
in NPCs; however, a similar trend like that in DNA and GAG 
content was detected. When costimulated with BMP2 and L51P, 
an increase was observed (Fig. 4D).
10. Metabolic Activity of IVD Cells in 3D Culture
Cell viability was measured every week (d7, d14, and d21) 
and normalized to the DNA content. The data demonstrated 
that the groups stimulated with OM possessed lower cell viabil-
ity at all 3-time points. When normalized to DNA content at 
day 21, groups stimulated with BM showed the trend of higher 
cell viability than OM groups (AFCs stimulated with CM: 17.0±  
1.2 and AFCs stimulated with OM: 7.9 ± 1.6. CEPCs showed 
overall the highest cell viability in the 3D culture (NPCs stimu-
lated with CM: 14.7± 2.9, AFCs stimulated with CM: 17.0± 1.2, 
AFC stimulated with CM: 23.0± 1.8; Fig. 5D).
11.  Visualization of Proteoglycans of IVD Cells in 3D 
Culture
Beads stained with Alcian blue for proteoglycan visualization 
showed the most robust proteoglycan staining in beads stimu-
lated with BM and supplemented with BMP2 and L51P (Fig. 6). 
Fig. 3. Gene expression of aggrecan (ACAN), collagen type 1 and type 2 (COL1, 2), and runt-related transcription factor 2 (RUNX2) 
in nucleus pulposus (NPCs), annulus fibrosus (AFCs), and cartilaginous endplate cells (CEPCs) cultured in 3-dimensional algi-
nate culture stimulated with osteogenic (OM) or basal medium (BM) supplemented with 100 ng/mL of bone morphogenetic 
protein 2 (BMP2) and/or L51P for 21 days. Results are presented as raw values and means (n = 2).
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This was especially the case for the CEPCs group. Also, beads 
stimulated with BM and supplemented with BMP2 or L51P 
showed more proteoglycan aggregation than those in other 
groups (Fig. 7). Generally, groups stimulated with OM and 
L51P and/or BMP2 showed weaker Alcian blue staining than 
groups stimulated with BM and L51P and/or BMP2.
DISCUSSION
In this study, we investigated the effect of BMP2 and L51P on 
primary human IVD cells, that is, NPCs, AFCs, and CEPCs. So 
far, some studies have been conducted on the effect of L51P in 
combination with BMP2 on primary murine osteoblasts, MC3-
T3-E1, ATCDC5 and pro-myoblasts.18-20 However, studies on 
primary human cells are very rare. Tekari et al.7 have shown 
that osteogenesis of human mesenchymal stem cells cocultured 
with human IVD cells can be rescued with the addition of L51P. 
Generally, all stimulations—BMP2 and L51P in CM and OM 
but also OM only—showed a tendency for ACAN and COL2 
upregulation. Interestingly, ACAN and COL2 showed the high-
est expression in NPCs in both groups stimulated with L51P 
and BMP2 (in BM and OM) compared with the corresponding 
media with single treatment. COL1 expression showed the same 
trend in NPCs stimulated with L51P and BMP2 in OM and ac-
cordingly to this RUNX2 expression was upregulated. This find-
ing for RUNX2 discriminated NPCs from AFCs and CEPCs 
under OM and could be related to their different origin during 
the development of NPCs. It was repeatedly demonstrated that 
NPCs are notochord-derived cells, which here were more re-
sponsive to OM than AFC and CEPC.
One of the main findings was also the generally higher up-
regulation of ACAN in all groups stimulated with OM compared 
with CM. ACAN and COL2 are among the most important pro-
ducts expressed by NPCs and were thus monitored in these cul-
tures. Anabolic effects of ACAN and COL2 because of BMP2 or 
BMP7 administration have been confirmed in various studies 
Fig. 4. Quantification of Glycosaminoglycan content (GAG) (A), DNA content (B), GAG/DNA ratio (C), total collagen content 
measured as hydroxyproline (OHP) (D) of nucleus pulposus (NPCs), annulus fibrosus (AFCs), and cartilaginous endplate cells 
(CEPCs) beads stimulated with osteogenic (OM) or basal medium (BM) supplemented with 100 ng/mL of bone morphogenetic 
protein 2 (BMP2) and/or L51P for 21 days. In panels A, B, and C, data are presented as min to max with all data points shown 
and in D data are shown as mean ± standard error of the mean. Kruskal-Wallis and Dunn multiple comparisons test (A, B, and 
C) to test statistical significance (n = 4) (*p < 0.0332).
A B
C D
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on different species (dogs, rabbits, rats, cows, and humans).22,28-30 
For COL1 expression, however, inconsistency prevails. Multiple 
groups like Kim et al.,30 Haschtmann et al.,22 and Lee et al.31 have 
shown an upregulation in COL1 in human IVD 3D culture, 
rabbit IVD explants and rabbit NPCs, all stimulated with exog-
enous BMP2 (rabbit IVD explants additionally with TGF-β3). 
However, others like Li et al.28 observed no changes in COL1 
gene expression after stimulation of rat AFC in vitro or after 
BMP2/BMP7 stimulation of bovine NPCs in a 3D fibrin-hyal-
uronan culture.29 Our findings showed that COL1 expression in 
NPCs stimulated with BMP2 and L51P was slightly upregulat-
ed. The COL1 expression level in CEPC generally showed the 
tendency for upregulation. Again, groups treated with BMP2 
and L51P tended to show the strongest effects.
Generally, beads cultured in OM lost transparency; they start 
to have a cloudy appearance and become brittle. Pravdyuk et 
al.32 also observed this with the cultivation of MSCs in alginate 
microspheres and stimulation with OM. Westhrin et al.33 also 
showed that mineralization of MSCs encapsulated beads be-
cause of OM stimulation.
GAG quantification of different groups matches the observa-
tion made in gene expression analysis only partially. GAG con-
tent was the highest in groups stimulated with BMP2 and L51P. 
However, in contrast to gene expression at day 7, GAG content 
measurement after 21 days showed higher concentrations in 
BM groups than in OM groups. The reduction of this chondro-
genic marker might be the effect of extensive β-glycerophosphate 
stimulation, which is contained in the OM. Continuing stimu-
lation with the OM might decrease chondrogenic differentia-
tion and instead induce matrix mineralization. Wu et al.,34 also 
observed this when stimulating ATDC5 cells with β-glycero-
phosphate; they confirmed early chondrogenesis with an up-
regulation of COL2 and ACAN and the production of a GAG-
rich matrix within the first 7 days. Beta-glycerophosphate de-
livery after early chondrogenesis further upregulated hypertro-
phic markers.34 GAG content was significantly higher in AFCs 
and CEPCs stimulated with BM + BMP2 and L51P than in BM 
control treatment. The same was observed for DNA content. 
Fig. 5. Metabolic activity after 7, 14, and 21 days of culture of nucleus pulposus (NPC) (A), annulus fibrosus (AFC) (B), and car-
tilaginous endplate cell (CEPC) (C) beads stimulated with osteogenic (OM) or basal medium (BM) supplemented with 100 ng/
mL of bone morphogenetic protein 2 (BMP2) and/or L51P. (D) Mitochondrial activity after 21 days of culture normalized to 
DNA content. Data are presented as min to max with all data points shown. Kruskal-Wallis and Dunn multiple comparisons test 
to test statistical significance was performed (n = 4) (*p < 0.0332).
A B
C D
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Fig. 6. Alcian blue staining for sulfated glycosaminoglycan visualization. Nucleus pulposus (NPC), annulus fibrosus (AFC), and 
cartilaginous endplate cell (CEPC) beads stimulated basal medium (BM) supplemented with 100 ng/mL of bone morphogenetic 
protein 2 (BMP2) and/or L51P. β-GP, β-glycerophosphate.
BM
BM+BMP2
BM+L51P
BM+
BMP2+
L51P
β-GP control
NPC AFC CEPC
Other studies have shown the beneficial effect of BMPs on cell 
proliferation.35 Interestingly, IVD cells cultured in OM generally 
presented the lower metabolic activity to DNA ratio than cells 
in BM.
Previous studies using L51P in combination with BMP2 have 
shown improved bone formation in a rat animal large bone de-
fect model and rat calvaria cells.16,19-21 In these studies, no osteo-
inductive effect could be obtained with L51P application alone. 
Surprisingly, in our experiment, we observed a comparable ef-
fect of BMP2 and L51P single application in gene expression 
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Fig. 7. Alcian blue staining for sulfated glycosaminoglycan visualization. Nucleus pulposus (NPC), annulus fibrosus (AFC), and 
cartilaginous endplate cell (CEPC) beads stimulated osteogenic medium (OM) supplemented with 100 ng/mL of bone morpho-
genetic protein 2 (BMP2) and/or L51P.
NPC AFC CEPC
OM
OM+BMP2
OM+L51P
OM+
BMP2+
L51P
and GAG content. While the ligand-binding affinity of BMPRI 
to L51P is lower compared with BMP2,16,17 the binding affinity 
of L51P to BMPRII is comparable to wild-type binding of BMP2. 
The binding affinity of L51P to BMP antagonists, such as NOG 
and GREM, was retained.17 The comparable results are explained 
by natural BMP antagonist expression, which has recently been 
shown.4,13 BMP antagonist expressed by IVD cells, which block 
regular BMPs, are inhibited by the presence of L51P and hence 
remain endogenous. BMP2 induces anabolic effects.
Newer studies have highlighted a new perspective that parts 
of the IVD tissue undergo osteogenic differentiation.4,22 This ig-
nited a debate among researchers about the possible use of BMP 
stimulation for IVD regeneration. The fact that IVD can ossify 
opens up a new direction for a possible treatment strategy in 
spinal fusion surgery. Many studies show the anabolic effect of 
BMPs on IVD, without consensus if BMPs facilitate chondro-
genic or an osteogenic phenotype of the cells. We studied BMP2 
and the BMP analogue L51P, which is a BMP antagonist inhibi-
tor but not an inducer of BMP signalling, and found that NPCs, 
AFCs, and CEPCs tended towards a chondrogenic rather than 
an osteogenic phenotype expression. However, few studies have 
been conducted to date with the BMP2 variant L51P in human 
cells, and further in vitro studies are in demand. Additionally, 
open questions remain, such as understanding the underlying 
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reason for L51P behaving in a similar manner to BMP2 in our 
experiments, or which L51P can inhibit BMP antagonists.
CONCLUSION
•  Exposure of BMP2 and L51P did not show any inhibiting 
effects on cyto-compatibility for any of the primary IVD 
cells, that is, NPCs, AFCs, and CEPCs.
•  Conversely, BMP2 in the combination of L51P enhanced 
mainly cell proliferation as revealed by an increase of DNA 
content, which resulted in an increased GAG production 
after 21 days.
•  However, the GAG/DNA ratio remained unchanged over 
time.
•  In OM, the IVD cells produced less GAG and were less met-
abolically active, possibly because of the onset of differentia-
tion or inhibiting factors of chondrogenesis.
•  For clinical relevance, these data confirm that application of 
the BMP2 analogue L51P does not negatively interfere with 
IVD cells but has a synergistic effect if applied in combina-
tion of BMP2 onto IVD cells.
•  L51P remains an interesting therapeutic molecule for the 
clinical application of improved spinal fusion.
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